Watch Ticker

Corvus Pharmaceuticals, Inc.

Go to Corvus Pharmaceuticals, Inc. Website

$4.28

-0.03 (-0.81%)

Live

Previous Close

$4.31

Day Range

$4.19 - $4.35

Previous Day Range

$4.12 - $4.365

Market Cap

$316.2 million USD

Day Vol.

206150

Previous Day Vol.

447986

Currency

USD

Primary Exchange

Nasdaq

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind s...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

Over 20 pharmaceutical companies are actively developing Interleukin-2 (IL-2) inhibitors to address autoimmune diseases and organ transplant procedures, with promising pipeline drugs in various clinical trial stages.

Related tickers: CRVS.

Read Full Article

Rishabh Mishra - US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak

U.S. stock futures climbed on Wednesday as investors await the Federal Reserve's interest rate decision and economic data releases. The Dow Jones index extended its losing streak to nine consecutive sessions, the longest since 1978.

Related tickers: CRVS, APDN.

Read Full Article

Trending Tickers

Please sign in to view